Showing results (521-530 of 542) with videos related to

Sort By:
Pageof 55
Diabetologia|October 5, 2011
Downregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotypeL Fuentes, K Wouters, S A Hannou, et al.
Clinical Pharmacology and Therapeutics|June 13, 2013
Profiling serum bile acid glucuronides in humans: gender divergences, genetic determinants, and response to fenofibrateJ Trottier, M Perreault, I Rudkowska, et al.
Biochemical and Biophysical Research Communications|March 1, 2000
Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbitsM Mackness, A Boullier, N Hennuyer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 17, 2004
REDD2 gene is upregulated by modified LDL or hypoxia and mediates human macrophage cell deathC Cuaz-Pérolin, C Furman, G Larigauderie, et al.
The Journal of Clinical Investigation|August 15, 1996
Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gammaP De Vos, A M Lefebvre, S G Miller, et al.
Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial studyR R Henry, B Staels, V A Fonseca, et al.
Arzneimittel-Forschung|June 3, 1998
Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugsB J van Vlijmen, N J Pearce, M Bergö, et al.
Atherosclerosis|February 13, 2001
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor bindingF H de Man, F de Beer, A van der Laarse, et al.
Diabetologia|June 16, 2000
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjectsD M Flavell, I Pineda Torra, Y Jamshidi, et al.
Journal of the American College of Cardiology|October 8, 1997
Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary AngioplastyM E Bertrand, E P McFadden, J C Fruchart, et al.
Pageof 55